If you are using brand-name pens with longer room temperature windows, a basic insulated case may be sufficient for short trips
[PubMed | DOI] Lincoff AM, Brown-Frandsen K, Colhoun HM, et al
Other GLP-1 pills like orforglipron are in advanced testing, but no GLP-1 patches are near approval
Based on the typical UK regulatory pathway, the most realistic timeline is: Late 2026 / early 2027: Eli Lilly expected to submit regulatory filings to the FDA and MHRA following completion of the remaining TRIUMPH Phase 3 readouts Late 2027 to mid-2028: Possible MHRA marketing authorisation, allowing private UK prescribing 2028 to 2029 onwards: Possible NHS availability following a NICE technology appraisal and NHS commissioning decisions Timelines may differ across the four UK nations, as Scotland, Wales, and Northern Ireland assess medicines separately through the Scottish Medicines Consortium (SMC), All Wales Medicines Strategy Group (AWMSG), and the Department of Health Northern Ireland respectively
"Some of those folks are going to get their hands on anorectic medicine and they're going to be able to drive their hunger into near non-existence," Mr Israetel says
They deliver clinically proven results, often with significant weight loss outcomes in medical trials
